General Information of Drug (ID: DM7I2AC)

Drug Name
mRNA-3745 Drug Info
Indication
Disease Entry ICD 11 Status REF
Glycogen storage disease type IA 5C51.3 Phase 1 [1]
Cross-matching ID
TTD Drug ID
DM7I2AC

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Glucose-6-phosphatase catalytic subunit 1 messenger RNA (G6PC1 mRNA) TTL5KSF G6PC1_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT05095727) A Phase 1/2, Adaptive, Open-label, Single Ascending Dose to Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-3745 in Participants With Glycogen Storage Disease Type 1a (GSD1a), Followed by an Open-label Extension. U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of Moderna